Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation (Q84045591)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Zeynep Arzu Yegin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Zübeyde Nur Ozkurt

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sahika Zeynep Aki

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Gülsan Türköz Sucak

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

10 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

239-245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Cellular therapy: donor lymphocyte infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor lymphocyte infusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Experimental and clinical approaches for optimization of the graft-versus-leukemia effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2010.03.011

10.1016/J.TRANSCI.2010.03.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20385512%20AND%20SRC:MED&resulttype=core&format=json